(v3.0.1.9149) Fix WHONET codes in microorganisms.codes that referred to unrelated microorganisms, let codes refer to the name they were named after and add a source column, and replace the fuzzy matching of WHONET names by exact matching with a guard against unreviewed remaps

WHONET names are now matched exactly (also outdated names, after removing qualifiers), then on GBIF identifier, and fuzzy results are only kept if consistent with that; otherwise the genus or UNKNOWN is used. A code refers to the record of the name it was named after (e.g. EAE is Enterobacter aerogenes) if that name refers to the same taxon. Every remap of an existing code to another taxon must be listed in data-raw/whonet_remaps_reviewed.csv; the 198 remaps of this rebuild were reviewed.
This commit is contained in:
dr. M.S. (Matthijs) Berends committed 2026-10-15 21:08:04 +02:00
1 parent 179eec584f
commit eb9a9c2fa5
29 files changed
+6711 -6095

No files matched your search

+4 -8
View File
@@ -20574,6 +20574,7 @@ Positive test: Isolates with gentamicin MIC >128 mg/L. The isolate is high-level
"EUCAST 2021" "human" "human" "MIC" "B_ACHRMB_XYLS" 2 "TZP" "A.xylosoxidans (file: Clinical Breakpoint Tables v. 11.0)" 4 4 FALSE FALSE "[1] For susceptibility testing purposes, the concentration of tazobactam is fixed at 4 mg/L."
"EUCAST 2021" "human" "human" "DISK" "B_ACNTB" 3.1 "AMC" "Acinetobacter (file: Clinical Breakpoint Tables v. 11.0)" FALSE FALSE "[No breakpoint] EUCAST gives - (susceptibility testing is not recommended)"
"EUCAST 2021" "human" "human" "MIC" "B_ACNTB" 3.1 "AMC" "Acinetobacter (file: Clinical Breakpoint Tables v. 11.0)" FALSE FALSE "[No breakpoint] EUCAST gives - (susceptibility testing is not recommended)"
"EUCAST 2021" "ECOFF" "ECOFF" "MIC" "B_ACNTB" 3 "AMK" "ECOFF" 8 8 FALSE FALSE
"EUCAST 2021" "human" "human" "DISK" "Infections originating from the urinary tract" "B_ACNTB" 3 "AMK" "Acinetobacter (file: Clinical Breakpoint Tables v. 11.0)" "30 mcg" 19 19 TRUE FALSE
"EUCAST 2021" "human" "human" "DISK" "B_ACNTB" 3.1 "AMK" "Acinetobacter (file: Clinical Breakpoint Tables v. 11.0)" FALSE FALSE "[No breakpoint] EUCAST gives breakpoints in brackets only (S (19), R (19)) | [( )] Breakpoints in brackets are based on ECOFF values for relevant species. They are used to distinguish between organisms with and without acquired resistance mechanisms. ECOFFs do not predict clinical susceptibility but in some situations and/or when the agent is combined with another active agent, therapy may be considered. | [A] For systemic infections, aminoglycosides must be used in combination with other active therapy. In this circumstance, the breakpoint/ECOFF in brackets can be used to distinguish between organisms with and without acquired resistance mechanisms. For isolates without resistance mechanisms, include a comment in the report: \"Aminoglycosides are often given in combination with other agents, either to support the activity of the aminoglycoside or to broaden the spectrum of therapy. In systemic infections, the aminoglycoside must be supported by other active therapy.\" For more information, see http://www.eucast.org/guidance_documents/."
"EUCAST 2021" "human" "human" "MIC" "Infections originating from the urinary tract" "B_ACNTB" 3 "AMK" "Acinetobacter (file: Clinical Breakpoint Tables v. 11.0)" 8 8 TRUE FALSE
@@ -20680,6 +20681,7 @@ Positive test: Isolates with gentamicin MIC >128 mg/L. The isolate is high-level
"EUCAST 2021" "human" "human" "MIC" "B_ACNTB" 3.1 "LMU" "Acinetobacter (file: Clinical Breakpoint Tables v. 11.0)" FALSE FALSE "[No breakpoint] EUCAST gives - (susceptibility testing is not recommended)"
"EUCAST 2021" "human" "human" "DISK" "B_ACNTB" 3.1 "LNZ" "Acinetobacter (file: Clinical Breakpoint Tables v. 11.0)" FALSE FALSE "[No breakpoint] EUCAST gives - (susceptibility testing is not recommended)"
"EUCAST 2021" "human" "human" "MIC" "B_ACNTB" 3.1 "LNZ" "Acinetobacter (file: Clinical Breakpoint Tables v. 11.0)" FALSE FALSE "[No breakpoint] EUCAST gives - (susceptibility testing is not recommended)"
"EUCAST 2021" "ECOFF" "ECOFF" "MIC" "B_ACNTB" 3 "LVX" "ECOFF" 0.5 0.5 FALSE FALSE
"EUCAST 2021" "human" "human" "DISK" "B_ACNTB" 3 "LVX" "Acinetobacter (file: Clinical Breakpoint Tables v. 11.0)" "5 mcg" 23 20 FALSE FALSE
"EUCAST 2021" "human" "human" "DISK" "Topical, Screen" "B_ACNTB" 3 "LVX" "Topical agents (file: Clinical Breakpoint Tables v. 11.0)" "5 mcg" 23 23 FALSE FALSE
"EUCAST 2021" "human" "human" "MIC" "B_ACNTB" 3 "LVX" "Acinetobacter (file: Clinical Breakpoint Tables v. 11.0)" 0.5 1 FALSE FALSE
@@ -20801,10 +20803,6 @@ Positive test: Isolates with gentamicin MIC >128 mg/L. The isolate is high-level
"EUCAST 2021" "ECOFF" "ECOFF" "MIC" "B_ACNTB_LWFF" 2 "IPM" "ECOFF" 1 1 FALSE FALSE
"EUCAST 2021" "ECOFF" "ECOFF" "MIC" "B_ACNTB_LWFF" 2 "MEM" "ECOFF" 2 2 FALSE FALSE
"EUCAST 2021" "ECOFF" "ECOFF" "MIC" "B_ACNTB_LWFF" 2 "TOB" "ECOFF" 2 2 FALSE FALSE
"EUCAST 2021" "ECOFF" "ECOFF" "MIC" "B_ACNTB_VNTN" 2 "AMK" "ECOFF" 8 8 FALSE FALSE
"EUCAST 2021" "ECOFF" "ECOFF" "MIC" "B_ACNTB_VNTN" 2 "CIP" "ECOFF" 1 1 FALSE FALSE
"EUCAST 2021" "ECOFF" "ECOFF" "MIC" "B_ACNTB_VNTN" 2 "LVX" "ECOFF" 0.5 0.5 FALSE FALSE
"EUCAST 2021" "ECOFF" "ECOFF" "MIC" "B_ACNTB_VNTN" 2 "TOB" "ECOFF" 4 4 FALSE FALSE
"EUCAST 2021" "human" "human" "DISK" "B_AERCC_SNGN" 2 "AMP" "A.sanguinicola_A.urinae (file: Clinical Breakpoint Tables v. 11.0)" "2 mcg" 26 26 FALSE FALSE
"EUCAST 2021" "human" "human" "MIC" "B_AERCC_SNGN" 2 "AMP" "A.sanguinicola_A.urinae (file: Clinical Breakpoint Tables v. 11.0)" 0.25 0.25 FALSE FALSE
"EUCAST 2021" "human" "human" "DISK" "B_AERCC_SNGN" 2.1 "AMX" "A.sanguinicola_A.urinae (file: Clinical Breakpoint Tables v. 11.0)" FALSE FALSE "[No breakpoint] EUCAST gives Note (see note) | [A] Infer susceptibility from ampicillin susceptibility."
@@ -25001,6 +24999,7 @@ Positive test: Isolates with gentamicin MIC >128 mg/L. The isolate is high-level
"EUCAST 2021" "human" "human" "MIC" "UNKNOWN" 7 "TZP" "PK PD breakpoints (file: Clinical Breakpoint Tables v. 11.0)" 8 16 FALSE FALSE "[PK-PD] These breakpoints are used only when there are no species-specific breakpoints or other recommendations (a dash or a note) in the species-specific tables. If the MIC is greater than the PK-PD resistant breakpoint, advise against use of the agent. If the MIC is less than or equal to the PK-PD susceptible breakpoint, suggest that the agent can be used with caution. The MIC may also be reported although this is not essential. Include a note that the guidance is based on PK-PD breakpoints only, and include the dosage on which PK-PD breakpoint is based.More information is available in the guidance document \"Antimicrobial susceptibility tests on groups of organisms or agents for which there are no EUCAST breakpoints\". | [3] For susceptibility testing purposes, the concentration of tazobactam is fixed at 4 mg/L."
"EUCAST 2020" "human" "human" "DISK" "B_ACNTB" 3.1 "AMC" "Acinetobacter (file: Clinical Breakpoint Tables v. 10.0)" FALSE FALSE "[No breakpoint] EUCAST gives - (susceptibility testing is not recommended)"
"EUCAST 2020" "human" "human" "MIC" "B_ACNTB" 3.1 "AMC" "Acinetobacter (file: Clinical Breakpoint Tables v. 10.0)" FALSE FALSE "[No breakpoint] EUCAST gives - (susceptibility testing is not recommended)"
"EUCAST 2020" "ECOFF" "ECOFF" "MIC" "B_ACNTB" 3 "AMK" "ECOFF" 8 8 FALSE FALSE
"EUCAST 2020" "human" "human" "DISK" "Infections originating from the urinary tract" "B_ACNTB" 3 "AMK" "Acinetobacter (file: Clinical Breakpoint Tables v. 10.0)" "30 mcg" 19 19 TRUE FALSE
"EUCAST 2020" "human" "human" "DISK" "B_ACNTB" 3.1 "AMK" "Acinetobacter (file: Clinical Breakpoint Tables v. 10.0)" FALSE FALSE "[No breakpoint] EUCAST gives breakpoints in brackets only (S (19), R (19)) | [( )] Breakpoints in brackets are based on ECOFF values for relevant species. They are used to distinguish between organisms with and without acquired resistance mechanisms. ECOFFs do not predict clinical susceptibility but in some situations and/or when the agent is combined with another active agent, therapy may be considered. | [A] For systemic infections, aminoglycosides must be used in combination with other active therapy. In this circumstance, the breakpoint/ECOFF in brackets can be used to distinguish between organisms with and without acquired resistance mechanisms. For isolates without resistance mechanisms, include a comment in the report: \"Aminoglycosides are often given in combination with other agents, either to support the activity of the aminoglycoside or to broaden the spectrum of therapy. In systemic infections, the aminoglycoside must be supported by other active therapy.\" For more information, see http://www.eucast.org/guidance_documents/."
"EUCAST 2020" "human" "human" "MIC" "Infections originating from the urinary tract" "B_ACNTB" 3 "AMK" "Acinetobacter (file: Clinical Breakpoint Tables v. 10.0)" 8 8 TRUE FALSE
@@ -25101,6 +25100,7 @@ Positive test: Isolates with gentamicin MIC >128 mg/L. The isolate is high-level
"EUCAST 2020" "human" "human" "MIC" "B_ACNTB" 3.1 "LEX" "Acinetobacter (file: Clinical Breakpoint Tables v. 10.0)" FALSE FALSE "[No breakpoint] EUCAST gives - (susceptibility testing is not recommended)"
"EUCAST 2020" "human" "human" "DISK" "B_ACNTB" 3.1 "LNZ" "Acinetobacter (file: Clinical Breakpoint Tables v. 10.0)" FALSE FALSE "[No breakpoint] EUCAST gives - (susceptibility testing is not recommended)"
"EUCAST 2020" "human" "human" "MIC" "B_ACNTB" 3.1 "LNZ" "Acinetobacter (file: Clinical Breakpoint Tables v. 10.0)" FALSE FALSE "[No breakpoint] EUCAST gives - (susceptibility testing is not recommended)"
"EUCAST 2020" "ECOFF" "ECOFF" "MIC" "B_ACNTB" 3 "LVX" "ECOFF" 0.5 0.5 FALSE FALSE
"EUCAST 2020" "human" "human" "DISK" "B_ACNTB" 3 "LVX" "Acinetobacter (file: Clinical Breakpoint Tables v. 10.0)" "5 mcg" 23 20 FALSE FALSE
"EUCAST 2020" "human" "human" "DISK" "Topical, Screen" "B_ACNTB" 3 "LVX" "Topical agents (file: Clinical Breakpoint Tables v. 10.0)" "5 mcg" 23 23 FALSE FALSE
"EUCAST 2020" "human" "human" "MIC" "B_ACNTB" 3 "LVX" "Acinetobacter (file: Clinical Breakpoint Tables v. 10.0)" 0.5 1 FALSE FALSE
@@ -25220,10 +25220,6 @@ Positive test: Isolates with gentamicin MIC >128 mg/L. The isolate is high-level
"EUCAST 2020" "ECOFF" "ECOFF" "MIC" "B_ACNTB_LWFF" 2 "IPM" "ECOFF" 1 1 FALSE FALSE
"EUCAST 2020" "ECOFF" "ECOFF" "MIC" "B_ACNTB_LWFF" 2 "MEM" "ECOFF" 2 2 FALSE FALSE
"EUCAST 2020" "ECOFF" "ECOFF" "MIC" "B_ACNTB_LWFF" 2 "TOB" "ECOFF" 2 2 FALSE FALSE
"EUCAST 2020" "ECOFF" "ECOFF" "MIC" "B_ACNTB_VNTN" 2 "AMK" "ECOFF" 8 8 FALSE FALSE
"EUCAST 2020" "ECOFF" "ECOFF" "MIC" "B_ACNTB_VNTN" 2 "CIP" "ECOFF" 1 1 FALSE FALSE
"EUCAST 2020" "ECOFF" "ECOFF" "MIC" "B_ACNTB_VNTN" 2 "LVX" "ECOFF" 0.5 0.5 FALSE FALSE
"EUCAST 2020" "ECOFF" "ECOFF" "MIC" "B_ACNTB_VNTN" 2 "TOB" "ECOFF" 4 4 FALSE FALSE
"EUCAST 2020" "human" "human" "DISK" "B_AERCC_SNGN" 2 "AMP" "A.sanguinicola_A.urinae (file: Clinical Breakpoint Tables v. 10.0)" "2 mcg" 26 26 FALSE FALSE
"EUCAST 2020" "human" "human" "MIC" "B_AERCC_SNGN" 2 "AMP" "A.sanguinicola_A.urinae (file: Clinical Breakpoint Tables v. 10.0)" 0.25 0.25 FALSE FALSE
"EUCAST 2020" "human" "human" "DISK" "B_AERCC_SNGN" 2.1 "AMX" "A.sanguinicola_A.urinae (file: Clinical Breakpoint Tables v. 10.0)" FALSE FALSE "[No breakpoint] EUCAST gives Note (see note) | [A] Infer susceptibility from ampicillin susceptibility."